伊藤病院 内科 部長
日本内科学会 総合内科専門医 日本内分泌学会 内分泌代謝科(内科)専門医・内分泌代謝科指導医・内分泌代謝・糖尿病内科領域 専門研修指導医・評議員 日本甲状腺学会 認定専門医・評議員・理事 日本糖尿病学会 糖尿病専門医 臨床遺伝専門医制度委員会 臨床遺伝専門医
続きを読む
日本内科学会 | 総合内科専門医 |
---|---|
日本内分泌学会 | 内分泌代謝科(内科)専門医・内分泌代謝科指導医・内分泌代謝・糖尿病内科領域 専門研修指導医・評議員 |
日本甲状腺学会 | 認定専門医・評議員・理事 |
日本糖尿病学会 | 糖尿病専門医 |
臨床遺伝専門医制度委員会 | 臨床遺伝専門医 |
伊藤病院
1997年
東邦大学医学部
卒業
2009年
東邦大学医学部 内科学講座(大森)糖尿病・代謝・内分泌科
助教
2010年
伊藤病院 内科
2016年
伊藤病院 内科
医長
2022年
伊藤病院 内科
部長
1. Prediction model of Graves' disease in general clinical practice based on complete blood count and biochemistry profile. Endocr J. 2022 Apr 5. doi: 10.1507/endocrj.EJ21-0741. Online ahead of print.
A. Yoshihara, J. Y. Noh, K. Inoue, J. Taguchi, K. Hata, T. Aizawa, Y. T. Arai, N. Watanabe, M. Fukushita, M. Matsumoto, N. Suzuki, A. Hoshiyama, A. Suzuki, T. Mitsumatsu, A. Kinoshita, K. Mikura, R. Yoshimura, K. Sugino, Koichi Ito.
2. The Relationship Between Primary Thyroid Lymphoma and Various Types of Thyroid Autoimmunity: A Retrospective Cohort Study of 498 Cases, Including 9 Cases with Graves' Disease. Thyroid. 2022;32:552-559.
N. Suzuki, N. Watanabe, J. Y. Noh, R. Yoshimura, K. Mikura, A. Kinoshita, A. Suzuki, T. Mitsumatsu, M. Fukushita, M. Matsumoto, A. Yoshihara, R. Katoh, K. Sugino, K. Ito.
3. Thyroid MALT lymphoma: self-harm to gain potential T-cell help. Leukemia. doi: 10.1038/s41375-021-01289-z, 2021, Online ahead of print.
F. Wu, N. Watanabe, M. M. Tzioni, A. Akarca. C. Zhang, Y. Li, Z.Chen, F. Cucco, N. Carmell, J. Y. Noh, K. Ito, R. Dobson, S. Moody, W. Yao, W. Zhang, W. Liu, H. Liu, J. Okosun, A. Chott, Y. Bi, S. S. Chuang, M. Raderer, J.Y. Li, T. Marafioti, M.Q.Du.
4. Delayed Follow-up Visits and Thyrotropin Among Patients With Levothyroxine During the COVID-19 Pandemic. J Endocr Soc
K. Inoue, J. Y. Noh, A. Yoshihara, N. Watanabe, M. Matsumoto, M. Fukushita, N. Suzuki, A. Hoshiyama, T. Mitsumatsu, A. Suzuki, A. Kinoshita, K. Mikura, R. Yoshimura, K. Sugino, K. Ito.
5. Survey of the actual administration of thiamazole for hyperthyroidism in Japan by the Japan Thyroid Association. Endocr J. doi:10.1507/endocrj. EJ21-0238, 2021, Online ahead of print.
N. Watanabe, J. Y. Noh, T. Akamizu, M. Yamada.
6. A case of macro-TSH consisting of IgA-bound TSH Endocr J. doi: 10.1507/endocrj.EJ21-0021, 2021 Online ahead of print.
M. Fukushita, N. Watanabe, J. Y. Noh, A. Yoshihara, M. Matsumoto, N. Suzuki, R. Yoshimura, K. Sugino, K. Ito.
7. Exposure to Propylthiouracil in the First Trimester of Pregnancy and Birth Defects: A Study at a Single Institution. J Endocr Soc. 2021 Jan 19;5(3):bvaa204. doi: 10.1210/jendso/bvaa204. eCollection 2021 Mar 1.
A. Yoshihara, J. Y. Noh, N. Watanabe, M. Fukushita, M. Matsumoto, N. Suzuki, A. Hoshiyama, A. Suzuki, T. Mitsumatsu, A. Kinoshita, K. Mikura, R. Yoshimura, K. Sugino, K. Ito.
8. Does Age or Sex Relate to Severity or Treatment Prognosis in Graves' Disease? Thyroid. doi: 10.1089/thy.2020.0881, 2021. Online ahead of print.
N. Suzuki, J. Y. Noh, R. Yoshimura, K. Mikura, A. Kinoshita, A. Suzuki, T. Mitsumatsu, A. Hoshiyama, M. Fukushita, M. Matsumoto, A. Yoshihara, N. Watanabe, K. Sugino, K. Ito.
9. Cardiac Troponin Is Elevated in Patients with Thyrotoxicosis and Decreases as Thyroid Function Improves and Brain Natriuretic Peptide Levels Decrease. Eur Thyroid J. DOI: 10.1159/000510619, 2020, online ahead of print.
N. Watanabe, J. Y. Noh, N. Hattori, K. Iwaku, N. Suzuki, A. Yoshihara, H. Ohye, M. Suzuki, M. Matsumoto, K. Endo, Y. Kunii, G. Takagi, K. Sugino, K. Ito.
10. Propylthiouracil-induced otitis media with anti-neutrophil cytoplasmic antibody-associated vasculitis: a case report and review of the literature. Endocr J. 68:145-151. 2020.
M. Hiruma, Y. Sasano, N. Watanabe, A. Yoshihara, S. Ishii, Y. Yaguchi, J. Y. Noh, K, Sugino, K. Ito.
11. Therapeutic efficacy and limitations of potassium iodide for patients newly diagnosed with Graves' disease. Endocr J. 67:631-638, 2020.
N. Suzuki, J. Y. Noh, C. Sugisawa, A. Hoshiyama, M. Hiruma, A. Kawaguchi, M. Morisaki, H. Ohye, M. Suzuki, M. Matsumoto, Y. Kunii, A. Yoshihara, N. Watanabe, K. Sugino, K. Ito.
12. Characteristics of Patients with Graves' Disease Whose Thyroid Hormone Levels Increase After Substituting Potassium Iodide for Methimazole in the First Trimester of Pregnancy. Thyroid.30:451-456, 2020
A. Yoshihara, J. Y. Noh, N. Watanabe, Y. Kunii, M. Suzuki, M. Matsumoto, N. Suzuki, M. Hiruma, M. Morisaki, A. Kawaguchi, K. Sugino K. Ito.
13. Analysis of Antithyroid Drug-Induced Severe Liver Injury in 18,558 Newly Diagnosed Patients with Graves' Disease in Japan. Thyroid. 29:1390-1398, 2019
N. Suzuki, J. Y. Noh, M. Hiruma, A. Kawaguchi, M. Morisaki, H. Ohye, M. Suzuki, M. Matsumoto, Y. Kunii, K. Iwaku, A. Yoshihara, N. Watanabe, K. Sugino, K. Ito.
14. Long-Term Outcomes of 107 Cases of Primary Thyroid Mucosa-Associated Lymphoid Tissue Lymphoma at a Single Medical Institution in Japan. J Clin Endocrinol Metab. 103:732-9, 2018
N. Watanabe, H. Narimatsu, J. Y. Noh, K. Iwaku, Y. Kunii, N. Suzuki, H. Ohye, M. Suzuki, M. Matsumoto, A. Yoshihara, K. Kameyama, K. Kobayashi, M. Kami, K. Sugino, K. Ito.
15. Substituting Potassium Iodide for Methimazole as the Treatment for Graves' Disease During the First Trimester May Reduce the Incidence of Congenital Anomalies: A Retrospective Study at a Single Medical Institution in Japan. Thyroid 25: 1155-1161, 2015
A. Yoshihara, J. Y. Noh, N. Watanabe, K. Mukasa, H. Ohye, M. Suzuki, M. Matsumoto, Y. Kunii, N. Suzuki, T. Kameda, K. Iwaku, S. Kobayashi, K. Sugino, K. Ito.
16. Radioiodine-Associated Exacerbation of Graves’ Orbitopathy in the Japanese Population: Randomized Prospective Study. J Clin Endocrinol Metab 100 : 2700-2708, 2015
N. Watanabe, J. Y. Noh, A. Kozaki, K. Iwaku, K. Sekiya, Y. Kosuga, M. Matsumoto, M. Suzuki, A. Yoshihara, H. Ohye, S. Kobayashi, Y. Kunii, K. Mukasa, K. Sugino, T. Inoue, K. Ito.
17. Rituximab-including combined modality treatment for primary thyroid lymphoma: an effective regimen for elderly patients. Thyroid 24: 994-999,2014
N. Watanabe, H. Narimatsu H, J.Y. Noh, Y. Kunii, K. Mukasa, M. Matsumoto, M. Suzuki, K. Sekiya, H. Ohye, A. Yoshihara, K. Iwaku, S. Kobayashi, K. Kameyama, K. Kobayashi, Y. Nishikawa, M. Kami, K. Sugino, K. Ito.
18. Antithyroid Drug-Induced Hematopoietic Damage: A Retrospective Cohort Study of Agranulocytosis and Pancytopenia Involving 50,385 Patients with Graves' Disease. J Clin Endocrinol Metab 97: E49-E53, 2012 (JCEM On-Line).
N. Watanabe, H. Narimatsu, J.Y. Noh, T. Yamaguchi, K. Kobayashi, M. Kami, Y. Kunii, K. Mukasa, K. Ito, K. Ito.
19. Treatment of Graves' disease with antithyroid drugs in the first trimester of paregnancy and the prevalence of congenital malformation. J Clin Endocrinol Metab 97: 2396-2403, 2012.
A. Yoshihara, J. Y. Noh, T. Yamaguchi, H. Ohye, Siori. Sato, K. Sekiya, Y. Kosuga, Miho suzuki, M. Matsumoto, Y. Kunii, N. Watanabe, K. Mukasa, K. Ito, K. Ito.
20. Clinicopathological features of 171 cases of primary thyroid lymphoma: a long-term study involving 24553 patients with Hashimoto's disease. British Journal of Haemaology 153: 236-243, 2011
N. Watanabe, J. Y. Noh, H. Narimatsu, K. Takeuch, T. Yamaguchi, K. Kameyama, K. Kobayashi, M. Kami, A. Kubo, Y. Kunii, T. Shimizu, K. Mukasa, F. Otsuka, A. Miyara, A. Minagawa, K. Ito, K. Ito.
1. 2007年 第23回甲状腺病態生理研究会 研究奨励賞
2. 2014年 第42回内分泌代謝研究会 研究特別賞
3. 2015年 第15回国際甲状腺学会 Young Investigator Travel Grant Award
4. 2016年 第45回日本甲状腺学会七條賞
本ページにおける情報は、医師本人の申告に基づいて掲載しております。内容については弊社においても可能な限り配慮しておりますが、最新の情報については公開情報等をご確認いただき、またご自身でお問い合わせいただきますようお願いします。
なお、弊社はいかなる場合にも、掲載された情報の誤り、不正確等にもとづく損害に対して責任を負わないものとします。